Access to medicines and global health: will Canada lead or flounder?
- PMID: 14734437
- PMCID: PMC315529
Access to medicines and global health: will Canada lead or flounder?
Comment in
-
Action on Canada's generic drug law.CMAJ. 2004 Apr 27;170(9):1374; author reply 1374-5. doi: 10.1503/cmaj.1040491. CMAJ. 2004. PMID: 15111456 Free PMC article. No abstract available.
References
-
- Bill C-56, An Act to amend the Patent Act and the Food and Drugs Act, 2d sess, 37th Parl, 2002–2003 (1st reading 6 Nov 2003). Available: www.parl.gc.ca/37/2/parlbus/chambus/house/bills/government/C-56/C-56_1/C... (accessed 11 Dec 2003).
-
- Statement by Stephen Lewis, the UN Secretary-General's Special Envoy for HIV/AIDS; 25 Sept 2003. Available: www.cptech.org/ip/health/c/canada/lewis09252003.html (accessed 11 Dec 2003).
-
- Hankins C. Overview of the AIDS pandemic. In: Presentations from the 6th International Conference on Healthcare Resource Allocation for HIV/AIDS; 2003 Oct 13; Washington (DC). Available: www.iapac.org/text/pdf/6thICHRAPresentations/hankinsFinalIapacAllocation... (accessed 13 Nov 2003).
-
- World Health Organization. WHO medicines strategy: framework for action in essential drugs and medicines policy 2002–2003. Geneva: The Organization; 2000. p. 36. Available: www.who.int/medicines/strategy/strategy.pdf (accessed 16 Dec 2003).
-
- World Trade Organization. Declaration on the TRIPS agreement and public health [Doha WTO Ministerial 2001: TRIPS]. Geneva: The Organization; 2001 Nov 14. Available: www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm (accessed 7 Nov 2003).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical